Standex International (SXI) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
The annual meeting is scheduled for October 22, 2024, at the corporate headquarters in Salem, NH, with voting available online, by phone, mail, or in person for shareholders of record as of August 28, 2024.
Shareholders will vote on five key proposals: election of three directors, amendment to the Omnibus Incentive Plan, advisory vote on executive compensation, amendment to the By-Laws, and ratification of independent auditors.
The Board recommends a vote FOR all proposals and has engaged Alliance Advisors to assist in proxy solicitation.
Voting matters and shareholder proposals
Proposal 1: Elect three directors (Robin J. Davenport, Jeffrey S. Edwards, B. Joanne Edwards) for three-year terms expiring in 2027.
Proposal 2: Approve an amendment to the 2018 Omnibus Incentive Plan to add 450,000 shares for future equity awards.
Proposal 3: Advisory vote on executive compensation (say-on-pay).
Proposal 4: Amend By-Laws to allow the Board, in addition to shareholders, to set the number of directors within the prescribed range.
Proposal 5: Ratify Deloitte & Touche LLP as independent auditors for FY 2025.
Board of directors and corporate governance
Board consists of eight directors, with 87.5% independent and 25% gender diversity; average tenure is 10.9 years.
Board committees: Audit, Compensation, Nominating & Corporate Governance, Innovation & Technology—all comprised solely of independent directors.
Annual board and committee self-evaluations, mandatory retirement age of 75, and periodic committee chair rotations.
Board leadership structure includes a combined Chair/CEO, Lead Independent Director, and regular executive sessions of independent directors.
Stock ownership guidelines and anti-hedging/pledging policies in place for directors and executives.
Latest events from Standex International
- Record profit, margin gains, and new launches set up >20% fast market growth for FY25.SXI
Q4 20242 Feb 2026 - Q2 FY26 delivered double-digit sales growth, margin expansion, and record order intake.SXI
Q2 20262 Feb 2026 - Record margin and a $462M acquisition set the stage for sequential growth.SXI
Q1 202518 Jan 2026 - Record sales and margins driven by acquisitions, but net income and cash flow declined.SXI
Q2 20259 Jan 2026 - Record margins and 17.2% sales growth driven by acquisitions and fast growth markets.SXI
Q3 202523 Dec 2025 - Annual meeting covers director elections, incentive plan, pay, by-law, auditor, and ESG focus.SXI
Proxy Filing1 Dec 2025 - 2025 meeting covers director elections, say-on-pay, auditor ratification, and ESG priorities.SXI
Proxy Filing1 Dec 2025 - Shareholders will vote on a By-Law Amendment needing 80% approval, with Board support.SXI
Proxy Filing1 Dec 2025 - Record Q4 sales and margin expansion set up $100M+ revenue growth and new launches in FY26.SXI
Q4 202516 Nov 2025